AABB.
Technical Manual: Methods and Appendices. 20th ed., AABB, 2020.
Food and Drug Administration. "Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products."
Food and Drug Administration, May 2023,
https://www.fda.gov/media/164829/download.
Food and Drug Administration. "Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Guidance for Industry; Availability."
Food and Drug Administration, May 2022,
https://www.fda.gov/media/124156/download.